The Stanford Arthritis Center (SAC) conducts research, educational and patient care programs to improve health outcomes of arthritic patients. In particular, SAC designs and implements new educational and community programs and guages their success by outcomes experienced by patients. To do so, SAC draws upon multi-faceted research activities, large numbers of patients and community physicians, cooperating hospitals and health services, a major system for managing data (ARAMIS), and skills of economists, epidemiologists, educators, and health professionals in assessing new programs. Central to SAC activities is development of reliable methods to evaluate health outcomes. SAC has developed instruments measuring functional status, symptoms, adverse effects of drugs and costs of health care for arthritic persons; other instruments, particularly concerning psychological variables and quality of life, are in developmental phases. This work depends upon a Core Unit which assists in experimental design, instrument development, data management and computational issues, biostatistics and data analysis. Seven successful programs will continue concerning: long term outcomes for rheumatoid arthritis, juvenile arthritis and joint replacement; self-management education for paatients; comparison of osteoarthritis outcomes in 3 different health services; comparison of team vs. individual physician care of chronic arthritis of the elderly; treatment of refractory lupus nephritis with total lymphoid irradiation. Six new projects are added, all related to chronic arthritis: identification of influential psychological factors; analysis of incidence by population characteristics; a new method for estimating indirect costs; the impact of exercise on incidence of osteoarthritis; distinction between seronegative and seropositive arthropathies; and search for a pathogenic antigen in cartilage of rheumatoid joints. Improved outcomes for arthritic patients nationally must occur within limits of financial resources. This Center develops and/or evaluates care programs for large groups of arthritic patients with the objective of improving the effectiveness, efficiency and satisfaction achieved by health services.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Comprehensive Center (P60)
Project #
5P60AR020610-17
Application #
2078458
Study Section
Arthritis and Musculoskeletal and Skin Diseases Special Grants Review Committee (AMS)
Project Start
1977-09-20
Project End
1997-06-30
Budget Start
1994-07-01
Budget End
1995-06-30
Support Year
17
Fiscal Year
1994
Total Cost
Indirect Cost
Name
Stanford University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
800771545
City
Stanford
State
CA
Country
United States
Zip Code
94305
Ward, M M; Marx, A S; Barry, N N (2002) Psychological distress and changes in the activity of systemic lupus erythematosus. Rheumatology (Oxford) 41:184-8
Lubeck, D P (2001) A review of the direct costs of rheumatoid arthritis: managed care versus fee-for-service settings. Pharmacoeconomics 19:811-8
Ward, M M; Marx, A S; Barry, N N (2000) Identification of clinically important changes in health status using receiver operating characteristic curves. J Clin Epidemiol 53:279-84
Ward, M M; Marx, A S; Barry, N N (2000) The rating scale preference measure as an evaluative measure in systemic lupus erythematosus. Lupus 9:696-701
Ward, M M; Marx, A S; Barry, N N (2000) Comparison of the validity and sensitivity to change of 5 activity indices in systemic lupus erythematosus. J Rheumatol 27:664-70
Calkins, H; Yong, P; Miller, J M et al. (1999) Catheter ablation of accessory pathways, atrioventricular nodal reentrant tachycardia, and the atrioventricular junction: final results of a prospective, multicenter clinical trial. The Atakr Multicenter Investigators Group. Circulation 99:262-70
Fischer, D; Stewart, A L; Bloch, D A et al. (1999) Capturing the patient's view of change as a clinical outcome measure. JAMA 282:1157-62
van Vollenhoven, R F; Park, J L; Genovese, M C et al. (1999) A double-blind, placebo-controlled, clinical trial of dehydroepiandrosterone in severe systemic lupus erythematosus. Lupus 8:181-7
Ward, M M; Lubeck, D; Leigh, J P (1998) Longterm health outcomes of patients with rheumatoid arthritis treated in managed care and fee-for-service practice settings. J Rheumatol 25:641-9
Hsieh, F Y; Bloch, D A; Larsen, M D (1998) A simple method of sample size calculation for linear and logistic regression. Stat Med 17:1623-34

Showing the most recent 10 out of 47 publications